Aimed at patients who are ineligible to take part in other clinical trials due to their advanced stage ALS, the trial hopes ...

Verge Genomics announced that Eli Lilly (LLY) has opted to pursue the development of therapeutics against two validated drug targets for ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

- VY1706 is the fifth neuro gene therapy development candidate nominated leveraging Voyager’s IV-delivered, CNS-penetrant TRACER capsids - ...

Amyotrophic Lateral Sclerosis (ALS) is a fatal type of motor neuron disease. It causes progressive degeneration of nerve ...

Neurizon Therapeutics Limited , a clinical-stage biotech company advancing treatments for neurodegenerative diseases, is ...

Lilly to Develop Two Targets Identified and Validated Using ’ AI-Enabled, All-in-Human CONVERGE® Platform — Demonstration of ...

A new AI-powered interpreter is expected to simulate speakers’ voices in different languages during Microsoft Teams meetings.

Alabama Governor Kay Ivey released a statement following the death of former State Finance Director Kelly Butler.Ivey said ...

The EMA recommended that NUZ-001, formerly monepantel, be granted orphan medicinal product designation to treat ALS in Europe ...

Since its founding, MediciNova has been clear in its mission to deliver new treatment options to the patients suffering with unmet medical needs. In service of that mission, we have been steadfast in ...